No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
US OptionsDetailed Quotes
BMEA241220P2500
- 0.03
- 0.000.00%
15min DelayTrading Dec 20 16:00 ET
0.00High0.00Low
0.00Open0.03Pre Close0 Volume4.19K Open Interest2.50Strike Price0.00Turnover0.00%IV36.18%PremiumDec 20, 2024Expiry Date0.00Intrinsic Value100Multiplier-10DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma129.00Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Intraday
- 5D
- Daily
News
Biomea Fusion Advances Diabetes Treatment With Positive Study Results
Truist Financial Maintains Biomea Fusion(BMEA.US) With Buy Rating
Express News | Biomea Fusion Inc : Scotiabank Cuts Target Price to $30 From $41
A Quick Look at Today's Ratings for Biomea Fusion(BMEA.US), With a Forecast Between $11 to $50
Barclays Remains a Hold on Biomea Fusion (BMEA)
Cautious Hold Rating on Biomea Fusion Amid Uncertainties in Drug Efficacy and Financial Outlook